Insider Trading History of Davis Stephen

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Davis Stephen since 2010. This trader's CIK number is 1131146. At the time of last reporting, Davis Stephen was the CEO of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD). Also see all insider trading activities at Acadia Pharmaceuticals Inc.

Note that in the past DAVIS STEPHEN also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Bellicum Pharmaceuticals, Inc (BLCM) by Davis Stephen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 BLCM 0 $0 0 $0 74,739 $0
2022 BLCM 0 $0 0 $0 62,115 $0

Yearly summary of insider trading at Heron Therapeutics, Inc. /de/ (HRTX) by Davis Stephen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 HRTX 0 $0 0 $0 120,313 $866,253

Yearly summary of insider trading at Intrabiotics Pharmaceuticals Inc /de (RDEA) by Davis Stephen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 RDEA 0 $0 700 $11,137 0 $0
2011 RDEA 0 $0 5,167 $130,099 0 $0
2010 RDEA 0 $0 351 $7,692 0 $0

Yearly summary of insider trading at Acadia Pharmaceuticals Inc (ACAD) by Davis Stephen

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 ACAD 0 $0 96,771 $1,720,018 94,864 $0
2023 ACAD 0 $0 247,308 $6,390,014 257,430 $2,077,000
2022 ACAD 0 $0 12,005 $229,721 31,090 $0
2021 ACAD 0 $0 28,492 $1,115,419 31,090 $0
2020 ACAD 0 $0 209,730 $9,707,872 221,562 $3,929,999
2019 ACAD 0 $0 302,983 $13,952,573 305,937 $5,894,999


Insider trading activities at 4 companies by Davis Stephen:

1. Bellicum Pharmaceuticals, Inc (BLCM)

2. Heron Therapeutics, Inc. /de/ (HRTX)

3. Intrabiotics Pharmaceuticals Inc /de (RDEA)

4. Acadia Pharmaceuticals Inc (ACAD)

Table 1. Insider trading of Bellicum Pharmaceuticals, Inc (BLCM) by Davis Stephen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-01-03 BLCM Option Ex 74,739 .00 0
2022-09-01 BLCM Option Ex 43,400 .00 0
2022-01-04 BLCM Option Ex 18,715 .00 0

Table 2. Insider trading of Heron Therapeutics, Inc. /de/ (HRTX) by Davis Stephen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-09-26 HRTX Option Ex 120,313 7.20 866,253

Table 3. Insider trading of Intrabiotics Pharmaceuticals Inc /de (RDEA) by Davis Stephen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-01-06 RDEA Sale 700 15.91 11,137
2011-11-15 RDEA Sale 432 18.86 8,145
2011-10-06 RDEA Sale 700 15.43 10,803
2011-07-06 RDEA Sale 700 25.65 17,957
2011-05-16 RDEA Sale 335 25.67 8,600
2011-04-08 RDEA Sale 3,000 28.20 84,594
2010-11-22 RDEA Sale 351 21.92 7,692

Table 4. Insider trading of Acadia Pharmaceuticals Inc (ACAD) by Davis Stephen

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-08-19 ACAD Sale 31,747 15.28 485,094
2024-05-02 ACAD Sale 11,427 16.94 193,573
2024-05-01 ACAD Option Ex 22,391 .00 0
2024-04-08 ACAD Sale 26,574 17.87 474,877
2024-04-05 ACAD Option Ex 51,999 .00 0
2024-03-27 ACAD Sale 17,714 17.90 317,080
2024-02-26 ACAD Sale 5,577 24.67 137,584
2024-02-23 ACAD Option Ex 10,946 .00 0
2024-01-08 ACAD Sale 3,732 29.96 111,810
2024-01-06 ACAD Option Ex 9,528 .00 0
2023-10-05 ACAD Option Ex 103,999 .00 0
2023-10-06 ACAD Sale 51,563 21.96 1,132,323
2023-07-14 ACAD Option Ex 100,000 20.77 2,077,000
2023-07-14 ACAD Sale 100,000 30.04 3,004,400
2023-07-11 ACAD Sale 16,498 25.00 412,450
2023-07-12 ACAD Sale 55,104 25.05 1,380,465
2023-05-01 ACAD Sale 7,806 21.18 165,331
2023-04-29 ACAD Option Ex 15,625 .00 0
2023-04-05 ACAD Option Ex 17,333 .00 0
2023-04-06 ACAD Sale 8,582 18.16 155,849
2023-02-23 ACAD Option Ex 10,945 .00 0
2023-02-24 ACAD Sale 3,851 18.78 72,321
2023-01-09 ACAD Sale 3,904 17.13 66,875
2023-01-06 ACAD Option Ex 9,528 .00 0
2022-10-15 ACAD Option Ex 5,938 .00 0
2022-10-15 ACAD Sale 2,804 15.81 44,331
2022-04-29 ACAD Option Ex 15,625 .00 0
2022-05-02 ACAD Sale 5,483 18.18 99,691
2022-01-06 ACAD Option Ex 9,527 .00 0
2022-01-06 ACAD Sale 3,718 23.05 85,699
2021-10-18 ACAD Sale 2,963 17.41 51,585
2021-10-15 ACAD Option Ex 5,938 .00 0
2021-04-29 ACAD Option Ex 15,625 .00 0
2021-04-30 ACAD Sale 7,850 20.33 159,590
2021-02-04 ACAD Sale 14,195 50.61 718,408
2021-01-06 ACAD Sale 3,484 53.34 185,836
2021-01-06 ACAD Option Ex 9,527 .00 0
2020-10-16 ACAD Sale 2,960 42.56 125,977
2020-10-15 ACAD Option Ex 5,937 .00 0
2020-05-13 ACAD Sale 111,458 46.97 5,234,959
2020-05-14 ACAD Sale 88,542 45.33 4,013,785
2020-05-13 ACAD Option Ex 111,458 19.65 2,190,149
2020-05-14 ACAD Option Ex 88,542 19.65 1,739,850
2020-04-29 ACAD Option Ex 15,625 .00 0
2020-04-30 ACAD Sale 6,770 49.21 333,151
2019-12-05 ACAD Option Ex 150,000 19.65 2,947,500
2019-12-05 ACAD Sale 150,000 52.08 7,811,550
2019-10-15 ACAD Option Ex 5,937 .00 0
2019-10-15 ACAD Sale 2,983 39.65 118,275
2019-10-10 ACAD Sale 120,208 40.19 4,831,039
2019-10-09 ACAD Sale 29,792 40.00 1,191,709
2019-10-10 ACAD Option Ex 120,208 19.65 2,362,087
2019-10-09 ACAD Option Ex 29,792 19.65 585,412

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Davis Stephen (CEO of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.